Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000921895-26-001270
Filing Date
2026-05-13
Accepted
2026-05-13 16:30:36
Documents
1
X0202

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 10827
  Complete submission text file 0000921895-26-001270.txt   12533
Mailing Address 138 ATLANTIC AVENUE BROOKLYN NY 11201
Business Address 138 ATLANTIC AVENUE BROOKLYN NY 11201 2122324582
Bandera Partners LLC (Filed by) CIK: 0001399386 (see all company filings)

EIN.: 205269850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A

Mailing Address 1875 W. WALNUT HILL LN #100 IRVING TX 75038
Business Address 1875 W. WALNUT HILL LN #100 IRVING TX 75038 972-486-9346
biote Corp. (Subject) CIK: 0001819253 (see all company filings)

EIN.: 851791125 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-92341 | Film No.: 26973898
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)